| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.OPHTHA.2012.05.027 |
| P8608 | Fatcat ID | release_g4l2wpg2xvcgbeckjphhemizv4 |
| P932 | PMC publication ID | 3485447 |
| P698 | PubMed publication ID | 22840421 |
| P50 | author | Emily Chew | Q24266614 |
| John Paul SanGiovanni | Q114678175 | ||
| Robert D Sperduto | Q114678183 | ||
| P2093 | author name string | Frederick L Ferris | |
| Amitha Domalpally | |||
| Wendy McBee | |||
| Ronald Danis | |||
| AREDS2 Research Group | |||
| Traci Clemons | |||
| P2860 | cites work | A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 | Q24544001 |
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9 | Q24546140 | ||
| Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc | Q28206868 | ||
| The Relationship of Dietary Carotenoid and Vitamin A, E, and C Intake With Age-Related Macular Degeneration in a Case-Control Study | Q28248143 | ||
| Prevalence of age-related macular degeneration in the United States | Q29614964 | ||
| Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey | Q32066253 | ||
| Omega-3 long-chain polyunsaturated fatty acid intake inversely associated with 12-year progression to advanced age-related macular degeneration | Q33613360 | ||
| The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23 | Q33613367 | ||
| Antioxidant intake and risk of incident age-related nuclear cataracts in the Beaver Dam Eye Study | Q33860147 | ||
| Lutein, zeaxanthin, and the macular pigment | Q33947513 | ||
| Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. | Q34182531 | ||
| Measurement of carotenoids, retinoids, and tocopherols in human lenses. | Q34290201 | ||
| Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group | Q34323879 | ||
| Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial | Q34405938 | ||
| Blood levels of vitamin C, carotenoids and retinol are inversely associated with cataract in a North Indian population | Q34590742 | ||
| A simplified severity scale for age-related macular degeneration: AREDS Report No. 18 | Q34655498 | ||
| Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study | Q34657635 | ||
| Associations between age-related nuclear cataract and lutein and zeaxanthin in the diet and serum in the Carotenoids in the Age-Related Eye Disease Study, an Ancillary Study of the Women's Health Initiative | Q34760523 | ||
| Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. | Q34805968 | ||
| The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina | Q35957608 | ||
| Lutein and age-related ocular disorders in the older adult: a review | Q37088727 | ||
| {omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study | Q37421203 | ||
| The impact of fish and shellfish consumption on age-related macular degeneration | Q37489484 | ||
| Dietary fatty acids and the 5-year incidence of age-related maculopathy | Q39761772 | ||
| Chemistry and metabolism of lipids in the vertebrate retina | Q40154390 | ||
| Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study | Q41654781 | ||
| Dietary fat and risk for advanced age-related macular degeneration | Q43694046 | ||
| Neovascular age-related macular degeneration and its relationship to antioxidant intake | Q44110946 | ||
| Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake | Q44684814 | ||
| Lutein and zeaxanthin and the risk of cataract: the Melbourne visual impairment project | Q45163501 | ||
| Prevalence of cataract and pseudophakia/aphakia among adults in the United States | Q46196467 | ||
| Lutein prevents cataract development and progression in diabetic rats. | Q46394442 | ||
| Dietary modulation of lens zeaxanthin in quail | Q46507277 | ||
| Causes and prevalence of visual impairment among adults in the United States | Q46890945 | ||
| Underwood Memorial LectureHuman Zinc Homeostasis: Good but Not Perfect | Q48570446 | ||
| Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. | Q53529956 | ||
| Associations Between Intermediate Age-Related Macular Degeneration and Lutein and Zeaxanthin in the Carotenoids in Age-Related Eye Disease Study (CAREDS) | Q63344335 | ||
| Oral zinc in macular degeneration | Q68126625 | ||
| Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-Control Study Group | Q72068439 | ||
| Xanthophylls and alpha-tocopherol decrease UVB-induced lipid peroxidation and stress signaling in human lens epithelial cells | Q81073258 | ||
| Cataract surgery and the primary care practitioner | Q83814283 | ||
| Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA Study | Q83839560 | ||
| P433 | issue | 11 | |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 2282-2289 | |
| P577 | publication date | 2012-07-26 | |
| P1433 | published in | Ophthalmology | Q7098109 |
| P1476 | title | The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1) | |
| P478 | volume | 119 |
| Q52818918 | A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14. |
| Q93150652 | A multi-task deep learning model for the classification of Age-related Macular Degeneration |
| Q42565175 | Advances in technology helps in early detection of vision disorders |
| Q26823002 | Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions |
| Q38330232 | An Evidence-Based Systematic Review of Lutein by the Natural Standard Research Collaboration |
| Q37645117 | Antioxidant drug therapy approaches for neuroprotection in chronic diseases of the retina |
| Q38653249 | Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. |
| Q48262215 | Approaches by the US National Institutes of Health to support rigorous scientific research on dietary supplements and natural products |
| Q34630065 | Aspirin use and risk of age-related macular degeneration: a meta-analysis |
| Q48553385 | Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13. |
| Q47335501 | Association of Rare Predicted Loss-of-Function Variants in Cellular Pathways with Sub-Phenotypes in Age-Related Macular Degeneration |
| Q90082786 | Atrophy in Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 15 |
| Q38877436 | Bivariate Analysis of Age-Related Macular Degeneration Progression Using Genetic Risk Scores |
| Q30540581 | Blue-light reflectance imaging of macular pigment in infants and children |
| Q36988482 | Botanical compounds: effects on major eye diseases |
| Q35827351 | Comparison of Mouse and Human Retinal Pigment Epithelium Gene Expression Profiles: Potential Implications for Age-Related Macular Degeneration |
| Q90692198 | Correlation between Macular Pigment Optical Density and Neural Thickness and Volume of the Retina |
| Q38611218 | Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data |
| Q92808731 | Current Trends in the Pharmacotherapy of Cataracts |
| Q99605502 | Dietary Patterns, Carbohydrates, and Age-Related Eye Diseases |
| Q38963195 | Dye solutions based on lutein and zeaxanthin: in vitro and in vivo analysis of ocular toxicity profiles. |
| Q34490891 | Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial |
| Q41845904 | Effect of supplemental lutein and zeaxanthin on serum, macular pigmentation, and visual performance in patients with early age-related macular degeneration |
| Q92990866 | Effects of Fish n-3 PUFAs on Intestinal Microbiota and Immune System |
| Q34353014 | European survey on the opinion and use of micronutrition in age-related macular degeneration: 10 years on from the Age-Related Eye Disease Study |
| Q42716529 | Evaluation of Geographic Atrophy from Color Photographs and Fundus Autofluorescence Images: Age-Related Eye Disease Study 2 Report Number 11. |
| Q37537304 | Genetic evidence for role of carotenoids in age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS). |
| Q44535356 | High concentrations of plasma n3 fatty acids are associated with decreased risk for late age-related macular degeneration |
| Q37265929 | Identification of a rare coding variant in complement 3 associated with age-related macular degeneration |
| Q38192127 | Is age-related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment |
| Q35491511 | Is aspirin use associated with age-related macular degeneration? A meta-analysis. |
| Q48095108 | Ischemic Retinopathies: Oxidative Stress and Inflammation. |
| Q34733171 | Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study |
| Q92301631 | Long-Chain Polyunsaturated Fatty Acids and Age-Related Macular Degeneration |
| Q34343037 | Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4. |
| Q28240096 | Macular xanthophylls, lipoprotein-related genes, and age-related macular degeneration |
| Q36996217 | Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2) |
| Q36678453 | Microglial aging in the healthy CNS: phenotypes, drivers, and rejuvenation |
| Q47606173 | Morphologic Criteria of Lesion Activity in Neovascular Age-Related Macular Degeneration: A Consensus Article |
| Q36926292 | Nutrient supplementation with n3 polyunsaturated fatty acids, lutein, and zeaxanthin decrease A2E accumulation and VEGF expression in the retinas of Ccl2/Cx3cr1-deficient mice on Crb1rd8 background |
| Q93140724 | Nutrition and Eye Health |
| Q38800270 | Nutrition, Genes, and Age-Related Macular Degeneration: What Have We Learned from the Trials? |
| Q89687694 | Nutritional Supplements for Age-Related Macular Degeneration |
| Q38317289 | Nutritional supplements in age-related macular degeneration |
| Q24186584 | Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration |
| Q55919856 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
| Q89958068 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
| Q90307768 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
| Q91677241 | Omega-3 fatty acids supplementation protects the retina from age-associated degeneration in aged C57BL/6J mice |
| Q38605292 | Optical Coherence Tomography Predictors of Risk for Progression to Non-Neovascular Atrophic Age-Related Macular Degeneration |
| Q51117668 | Optical Coherence Tomography Reflective Drusen Substructures Predict Progression to Geographic Atrophy in Age-related Macular Degeneration. |
| Q46248374 | Oxidative stress and reactive oxygen species: a review of their role in ocular disease |
| Q37627442 | Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization |
| Q36890365 | Perspective: A Critical Look at the Ancillary Age-Related Eye Disease Study 2: Nutrition and Cognitive Function Results in Older Individuals with Age-Related Macular Degeneration |
| Q57689012 | Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease |
| Q93360900 | Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease |
| Q35746909 | Potential role of lampalizumab for treatment of geographic atrophy |
| Q99239361 | Predicting risk of late age-related macular degeneration using deep learning |
| Q33562731 | Present and possible therapies for age-related macular degeneration. |
| Q90314602 | Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21 |
| Q56243532 | Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16 |
| Q37513827 | Quantitative classification of eyes with and without intermediate age-related macular degeneration using optical coherence tomography |
| Q37570185 | Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study |
| Q38696053 | Risk of Deficiency in Multiple Concurrent Micronutrients in Children and Adults in the United States. |
| Q91994298 | Saffron: A Multitask Neuroprotective Agent for Retinal Degenerative Diseases |
| Q36257030 | Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3 |
| Q57795780 | Semivariogram and Semimadogram functions as descriptors for AMD diagnosis on SD-OCT topographic maps using Support Vector Machine |
| Q88615813 | Supplementation with macular carotenoids improves visual performance of transgenic mice |
| Q39092535 | The Age-Related Eye Disease 2 Study: Micronutrients in the Treatment of Macular Degeneration |
| Q36315753 | The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9 |
| Q36730429 | The Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8 |
| Q92982650 | The Role of Fish Oil in Inflammatory Eye Diseases |
| Q37002600 | The role of lutein in eye-related disease |
| Q89928637 | Therapeutic potential of omega-3 fatty acids supplementation in a mouse model of dry macular degeneration |
| Q33717538 | Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5. |
| Q86603541 | [Supplements in age-related macular degeneration: recommendations by the German Ophthalmological Society, the German Retina Society and the German Professional Association of Ophthalmologists--October 2014] |
| Q36374238 | ω-3 and ω-6 long-chain PUFAs and their enzymatic metabolites in neovascular eye diseases. |
Search more.